Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 12, Issue 12, 1993, Pages 897-906

  de Marie, S ^a,b   van den Broek, P J ^a   Willemze, R ^a   van Furth, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAMANDOLE; COTRIMOXAZOLE; CYTARABINE; FLUCONAZOLE; GENTAMICIN; IMIPENEM; NEOMYCIN; PENICILLIN G; PIPEMIDIC ACID; POLYMYXIN B; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CANCER; DRUG SPECIFICITY; FEVER; HEMATOLOGIC DISEASE; HUMAN; INFECTION COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUTROPENIA; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; ANTIBIOTICS; BACTERIAL INFECTIONS; FEVER; HUMAN; MIDDLE AGE; MYCOSES; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 0027756945     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01992162     Document Type: Article

References (36)

1. Origin of infection in acute nonlymphocytic leukemia
2. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia
3. Clinical presentation of infection in granulocytopenic patients
4. Empirical therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia
5. Empirical antibiotic therapy
6. Therapy of infection in patients with granulocytopenia
7. Empirical antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
8. Approaching the controversies in antibacterial management of cancer patients
9. Pseudomonas bacteremia: retrospective analysis of 410 episodes
10. Controversies in the management of febrile neutropenic cancer patients
11. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
12. Management of fever in patients with cancer and treatment-induced neutropenia
13. Improved prognosis for granulocytopenic patients with gram-negative bacteremia
14. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
15. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract
16. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytyc leukemia: a double blind placebo-controlled study
17. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with haematologic malignancies
18. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin
19. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double blind, placebo-controlled trial
20. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation
21. Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28965) in granulocytopenic patients receiving ciprofloxacin
22. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy
23. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients
24. Stopping antibiotic therapy in neutropenic patients
25. Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
26. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed leukaemia and non-Hodgkin's lymphoma
27. The effect of different measures of outcome on the results of studies of empirical antibiotic therapy in febrile neutropenic patients
28. Duration of empirical antibiotic therapy in granulocytopenic patients with cancer
29. After empirical therapy: what to do until the granulocyte comes back
30. Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients
31. Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin
32. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors
33. Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients
34. Fungal infections of the immunocompromised host: clinical and laboratory aspects
35. Empirical antifungal therapy in febrile granulocytopenic patients
36. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness